Repurposing the antihistamine drug bilastine as an anti-cancer metallic drug entity: synthesis and single-crystal X-ray structure analysis of metal-based bilastine and phen [Co( ii ), Cu( ii ) and Zn( ii )] tailored anticancer chemotherapeutic agents against resistant cancer cells
Dalton Transactions · 2024
DOI: 10.1039/d4dt00426d ↗Kurz gefasst
Fachartikel in der Zeitschrift Dalton Transactions, 2024. Verfasst von Rijwan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Aligarh Muslim University, Aligarh, UP 202002, India. tsartaj62@yahoo.com. Hauptthemen laut MEDLINE: Antineoplastic Agents, Copper, Zinc, Coordination Complexes. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 49 Literaturangaben.
Abstract (Originalsprache)
New Bilastine derived metal based drugs have been synthesized and evaluated for their anticancer potential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Aligarh Muslim University, Aligarh, UP 202002, India. tsartaj62@yahoo.com.
Zitieren
APA
Rijwan, Arjmand, F., & Tabassum, S. (2024). Repurposing the antihistamine drug bilastine as an anti-cancer metallic drug entity: synthesis and single-crystal X-ray structure analysis of metal-based bilastine and phen [Co( ii ), Cu( ii ) and Zn( ii )] tailored anticancer chemotherapeutic agents against resistant cancer cells. Dalton Transactions. https://doi.org/10.1039/d4dt00426d
Vancouver
Rijwan, Arjmand F, Tabassum S. Repurposing the antihistamine drug bilastine as an anti-cancer metallic drug entity: synthesis and single-crystal X-ray structure analysis of metal-based bilastine and phen [Co( ii ), Cu( ii ) and Zn( ii )] tailored anticancer chemotherapeutic agents against resistant cancer cells. Dalton Transactions. 2024. doi:10.1039/d4dt00426d
BibTeX
@article{Rijwan2024,
author = {Rijwan and Arjmand, Farukh and Tabassum, Sartaj},
title = {Repurposing the antihistamine drug bilastine as an anti-cancer metallic drug entity: synthesis and single-crystal X-ray structure analysis of metal-based bilastine and phen [Co( ii ), Cu( ii ) and Zn( ii )] tailored anticancer chemotherapeutic agents against resistant cancer cells},
journal = {Dalton Transactions},
year = {2024},
doi = {10.1039/d4dt00426d}
}
EUVIMED